Emcure Pharmaceuticals Ltd (EMCURE) — promoter pledge

Pledged promoter shares first appear in Emcure Pharmaceuticals Ltd's Mar 2025 filing. Pledged promoter shares have never exceeded 0.05% of promoter holding in any filed quarter. A pledge is reported in 6 of the 8 quarters of promoter shareholding data Solomo holds for this company.

One member of the promoter group reports pledged shares in Jun 2026: Smita Paresh Shah (0.06% of the company, 55.8% of it pledged).

Ranked by share of promoter holding pledged, Emcure Pharmaceuticals Ltd is #535 of the 563 listed Indian companies whose latest quarterly filing reports any pledged promoter shares.

A promoter pledge means a promoter has put their own shares up as collateral, usually against a loan. It is legal and common, and SEBI requires it to be disclosed every quarter in the shareholding pattern. It matters to other shareholders because a sharp fall in the share price can trigger a margin call: if the promoter cannot top up the collateral, the lender can invoke the pledge and sell those shares in the open market, which adds selling pressure to an already falling price and, at high pledge levels, can change who controls the company. The percentage on its own is not a verdict — the level, the direction of travel and what the borrowing funded all matter.